Home
Ascend Gene & Cell Therapies

Ascend Gene & Cell Thera... Market Share Analysis for June 2026

See what makes Ascend a gene therapy partner of choice.

Industry: N/A

Domainascend-gctx.com

Year Founded2021

Employees51 - 200

Annual Revenue--

Ascend Gene & Cell Therapies

Ascend Gene & Cell Therapies (including company regionals)

ascend-gctx.com

See more website traffic and engagement information

Total visits to Ascend Gene & Cell Therapies's top domains

Understand Ascend Gene & Cell Therapies market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Ascend Gene & Cell Therapies's top domains

Analyze Ascend Gene & Cell Therapies engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Ascend Gene & Cell Therapies's top domains

See how Ascend Gene & Cell Therapies keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Ascend Gene & Cell Therapies top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Ascend Gene & Cell Therapies

These are the website technologies, by industry, used by Ascend Gene & Cell Therapies top domains

Email Services (2)

G Suite

Payment & Currencies (2)

Cart Functionality

Business Solutions (1)

DocuSign

Comments System (1)

Disqus

More Technologies

6

See all

News & Signals from Ascend Gene & Cell Therapies

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAscend Gctx received financing of $133M in Series A on Apr 9th '23.Originally founded by Monograph Capital, Ascend has raised a total of $132.5M, most recently completing a Series A fundraise led by Abingworth and Petrichor, supported by DCVC Bio, 4BIO Capital, Cathay Health, Deerfield Management, Digitalis Ventures and Ajinomoto Co., Inc.